top of page

Spectral effects of UV on Psoriasis

Ultraviolet B (UVB) is an effective, safe, and affordable treatment for moderate psoriasis, using both broadband and narrowband lamps. This paper explores the current literature and proposes using keratinocyte apoptosis as a biomarker to optimize UVB treatment, potentially allowing for a more tailored and effective approach to phototherapy.

Illuminating Eczema: A Comprehensive Assessment of Phototherapy Efficacy A Systematic Review and Meta-Analysis

This meta-analysis evaluates the efficacy of phototherapy in treating eczema, highlighting its potential as a viable therapeutic option. By synthesizing data from various studies, the review examines the impact of different phototherapy modalities, including NB-UVB and UVA, on eczema outcomes such as pruritus, erythema, disease severity, and quality of life. The findings suggest that phototherapy, particularly NB-UVB, can significantly improve eczema symptoms and inform clinical decisions regarding its use in managing this chronic skin condition.

Bridging Molecular Mechanism and Clinical Practice in Vitiligo Treatment: An Updated Review

The treatment of vitiligo aims to stop disease progression, regenerate pigmentation, and prevent recurrence. This review discusses various nonsurgical interventions like phototherapy, topical and systemic agents, and new treatments like JAK inhibitors, highlighting the importance of understanding molecular mechanisms to optimize therapeutic outcomes for vitiligo.

An Update on Narrowband Ultraviolet B Therapy for the Treatment of Skin Diseases

This review highlights the effectiveness and clinical tolerability of narrowband ultraviolet B (NB-UVB) for treating various inflammatory skin conditions, including vitiligo, psoriasis, and atopic dermatitis. The study found that NB-UVB remains a viable treatment option, with home-based phototherapy offering comparable efficacy to office-based treatments, especially significant during the COVID-19 pandemic. The combination of NB-UVB with Janus kinase inhibitors shows promising potential for vitiligo treatment.

Narrow‐band ultraviolet B phototherapy versus broad‐band ultraviolet B or psoralen‐ultraviolet A photochemotherapy for psoriasis - Cochrane Review

This Cochrane review assessed the efficacy of narrow-band UVB (NB-UVB) phototherapy versus broad-band UVB (BB-UVB) and psoralen UVA (PUVA) for treating psoriasis. It involved a comprehensive search of multiple databases up to August 2013. The aim was to resolve the controversy over the relative effectiveness of these phototherapy treatments.

Interventions for vitiligo - Cochrane Review

This Cochrane review evaluated the effectiveness of various treatments for vitiligo, a chronic skin disorder characterized by patchy loss of skin color. Affecting around 1% of the global population, vitiligo often begins before age 20 and can present as either generalised or segmental. The review involved a comprehensive search of several databases up to October 2013 to identify relevant randomized controlled trials. The goal was to assess the efficacy of different therapeutic interventions for managing vitiligo.

Phototherapy for atopic eczema - Cochrane Review

This Cochrane review evaluated the effectiveness of phototherapy for treating atopic eczema (AE), a chronic inflammatory skin condition. The objective was to assess phototherapy's efficacy compared to other treatments when topical treatments are insufficient. A comprehensive search of several databases up to January 2021 identified randomized controlled trials involving adults and children with AE, comparing various types of phototherapy against other treatments, including placebos.

bottom of page